P39 Establishing minimally important differences for cardiac MRI endpoints in pulmonary arterial hypertension

S Alabed,P Garg,F Alandejani,K Dwivedi,A Maiter,K Karunasaagarar,S Rajaram,C Hill,S Thomas,M Sharkey, JM Wild,L Watson,A Charalampopoulos,A Hameed,I Armstrong, R Condliffe,AJ Swift,DG Kiely

‘Mission (Im)possible I’ – Pulmonary vascular disease（2022）

引用 0|浏览2

暂无评分

摘要

This study establishes clinically relevant CMR MIDs for how a patient feels, functions or survives in response to PAH treatment. These findings provide further support for the use of CMR as a clinically relevant clinical outcome measure and will aid trial-size calculations for studies using CMR.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要